Although just in its 20th year, the Weldon School of Biomedical Engineering has synergistically leveraged Purdue's and Indiana University School of Medicine’s (IUSM) expansive engineering and medical infrastructure, respectively, to rapidly create one of the most productive translational research enterprises.
Through an array of company partners in the medical device, biotechnology, and pharmaceutical fields, licenses of clinical technologies have generated over $20M in royalties from products that have directly helped more than two million patients worldwide. In addition, the strong entrepreneurial spirit of faculty members has resulted in the launch of more than two dozen life science startup companies with over $75M in venture capital raised and more than 50 technologies licensed to major company partners.
Currently, Weldon School-based diagnostic and therapeutic innovations are in over 20 active clinical trails.